ZA907944B - Hiv related peptides - Google Patents

Hiv related peptides

Info

Publication number
ZA907944B
ZA907944B ZA907944A ZA907944A ZA907944B ZA 907944 B ZA907944 B ZA 907944B ZA 907944 A ZA907944 A ZA 907944A ZA 907944 A ZA907944 A ZA 907944A ZA 907944 B ZA907944 B ZA 907944B
Authority
ZA
South Africa
Prior art keywords
hiv
terminal
related peptides
hiv related
peptides
Prior art date
Application number
ZA907944A
Inventor
Paul H Naylor
H Naylor Paul
Su Sun Wang
Sun Wang Su
Original Assignee
Univ George Washington
Viral Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23666609&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA907944(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ George Washington, Viral Technologies Inc filed Critical Univ George Washington
Publication of ZA907944B publication Critical patent/ZA907944B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Abstract

Fragments of HIV p17 protein ranging in length from about 12 to about 40 amino acids are used to form diagnostics and vaccines for detection or treatment of AIDS. Specific peptide fragments extend from the N-terminal to the C-terminal. Peptides having the amino acid sequences shown by the following formula (I), (II), (III), (IV) and (V):are immunoreactive to antibodies in sera of patients testing seropositive for p17 of HIV-1.
ZA907944A 1989-10-12 1990-10-04 Hiv related peptides ZA907944B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42046989A 1989-10-12 1989-10-12

Publications (1)

Publication Number Publication Date
ZA907944B true ZA907944B (en) 1991-10-30

Family

ID=23666609

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA907944A ZA907944B (en) 1989-10-12 1990-10-04 Hiv related peptides

Country Status (17)

Country Link
EP (3) EP0426314B1 (en)
JP (1) JPH03209398A (en)
KR (1) KR910007962A (en)
CN (1) CN1052310A (en)
AT (1) ATE119166T1 (en)
AU (1) AU6393990A (en)
CA (1) CA2027455A1 (en)
DE (1) DE69017352T2 (en)
DK (1) DK0426314T3 (en)
ES (1) ES2071038T3 (en)
GB (1) GB2236754A (en)
GR (1) GR3015244T3 (en)
HU (1) HUT55035A (en)
IE (1) IE67533B1 (en)
IL (1) IL95890A0 (en)
NZ (1) NZ235538A (en)
ZA (1) ZA907944B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4039925A1 (en) * 1990-12-14 1992-06-17 Behringwerke Ag SELECTED PEPTIDES OF THE GROUP-SPECIFIC ANTIGEN (GAG) OF HUMANEM IMMUNE DEFICIENCY VIRUS (HIV), THEIR PRODUCTION AND USE
FR2734281B1 (en) * 1995-05-18 1997-07-25 Commissariat Energie Atomique NUCLEIC ACID FRAGMENTS DERIVED FROM THE GENOME OF HIV-1 VIRUS, CORRESPONDING PEPTIDES AND THEIR APPLICATIONS AS REAGENTS FOR ASSESSING THE RISK OF MATERNAL-FETAL TRANSMISSION OF HIV-1
US6103239A (en) * 1996-08-09 2000-08-15 Cel-Sci Corporation Modified HGP-30 heteroconjugates, compositions and methods of use
NO314588B1 (en) 2000-09-04 2003-04-14 Bionor Immuno As HIV peptides, antigens, vaccine composition, immunoassay test kits and a method for detecting antibodies induced by HIV
DK1417222T3 (en) 2001-08-07 2010-12-13 Medestea Res & Production S P A Isolated polypeptides based on the neutralizing epitope of the p17 protein from HIV suitable for vaccines as well as neutralizing anti-p17 antibodies that specifically recognize said neutralizing epitope

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62164696A (en) * 1986-01-06 1987-07-21 エフ．ホフマン　―　ラ　ロシュ　アーゲー Development of htlv-iiigag gene
ZA873215B (en) * 1986-05-19 1987-10-28 Viral Technologies Inc. Htlv-iii/lav virus related peptides,antibodies to the peptides,vaccines,passive and active immunization against aids virus and diagnostic test for the serological detection of aids virus
DE3787002T2 (en) * 1986-12-30 1993-11-25 Us Health Synthetic peptides that generate cellular immunity to the AIDS virus and its proteins.
NO881151L (en) * 1987-03-27 1988-09-28 Syntello Ab SYNTHETIC HIV-1 ANTIGEN.
DK643188A (en) * 1987-11-24 1989-05-25 Smithkline Biolog EXPRESSION OF HIV PROTEINS IN E.COLI AND S.CEREVISIAE
EP0330359A3 (en) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition useful in the diagnosis and treating of hiv-1 infection

Also Published As

Publication number Publication date
GB9021942D0 (en) 1990-11-21
CA2027455A1 (en) 1991-04-13
NZ235538A (en) 1992-06-25
IE903604A1 (en) 1991-04-24
ATE119166T1 (en) 1995-03-15
ES2071038T3 (en) 1995-06-16
CN1052310A (en) 1991-06-19
HU906421D0 (en) 1991-04-29
HUT55035A (en) 1991-04-29
IL95890A0 (en) 1991-07-18
EP0426314A3 (en) 1991-07-24
GR3015244T3 (en) 1995-06-30
DK0426314T3 (en) 1995-03-27
EP0426314A2 (en) 1991-05-08
EP0620010A1 (en) 1994-10-19
DE69017352T2 (en) 1995-10-05
GB2236754A (en) 1991-04-17
EP0620009A1 (en) 1994-10-19
AU6393990A (en) 1991-04-18
IE67533B1 (en) 1996-04-03
KR910007962A (en) 1991-05-30
JPH03209398A (en) 1991-09-12
DE69017352D1 (en) 1995-04-06
EP0426314B1 (en) 1995-03-01

Similar Documents

Publication Publication Date Title
ATE373010T1 (en) GAG ANTIGEN AND ITS USE FOR DETECTING LAV INFECTION, AND IN IMMUNOGENIC COMPOSITIONS
DE60026332D1 (en) DIAGNOSIS OF DOMESTIC SPRUE / CELIAC DISEASE WITH THE HELP OF GLIADINE PITOPENES
ES2013346A6 (en) Dna sequences, recombinant dna molecules and processes for producing soluble t4 proteins.
AU1353295A (en) Peptides derived from a retrovirus of the HIV group, and their use
DE68928130T2 (en) Synthetic peptides derived from HIV-GP120-env protein and their application
IL152507A0 (en) Methods and compositions for impairing multiplication of hiv-1
US4755380A (en) Peptide from amyloid A and antiserum therefor
GB9021942D0 (en) Hiv related peptides
EP0177814A3 (en) Peptide antibodies and their use in detecting oncogene products
EP0330700A4 (en) Human prourokinase-like polypeptide.
DE69012989D1 (en) PEPTIDES OF RETINBLASTOMA GENE PRODUCTS AND ANTIBODIES AGAINST.
GB2299994B (en) Equine arteritis virus peptides; antibodies and their use in a diagnostic test
PT87239A (en) PROCESS FOR THE PREPARATION OF PEPTIDES
TH9844A (en) HIV-associated peptides
HUP9900766A2 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
TH9844EX (en) HIV-associated peptides
WO1991009872A3 (en) Hiv-1 env fragment fusion protein